Search published articles


Showing 2 results for C S

Mohit Kumar , Jayaprakash C S , Athira K P,
Volume 19, Issue 2 (3-2025)
Abstract

Background: Non-Hodgkin lymphoma (NHL) represents a heterogeneous group of lymphoproliferative malignancies with unique presentation and treatment response. This study was intended to assess the histomorphology of non-Hodgkin lymphoma subtypes and correlate with clinicopathological and immunohistochemical findings.
Methods: This retrospective study was conducted on all specimens diagnosed as NHL by histopathological analysis, with immunohistochemical correlation in the pathology department, for two years. Clinical details such as age, gender, site of the lesion, and Nodal / extranodal presentation were recorded. Histopathological analysis was performed, and Immunohistochemical (IHC) reports were obtained. Further histopathological findings were correlated with IHC results. Statistical analysis was done based on the frequency distribution.
Results: This study includes 48 cases. Most cases are 61 to 70 years old, with a male predominance (56.25 %). The most common clinical diagnosis was lymphoma (79.17 %).  Most of the lesions were of lymph nodal origin (60.42 %). The cervical group (35.42 %) is the most common lymph node affected, followed by the axillary nodes. The most common extranodal sites are the retroperitoneum and stomach. On histopathological evaluation, the most common diagnosis was NHL (68.75 %) without further subtyping. Among cases where subtyping was done, the most common lesion were follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). On IHC evaluation, B cell neoplasms (85.42%) were common compared to T cell neoplasms (14.58 %). The most common subtype was DLBCL (52.08 %), followed by follicular lymphoma (16.67 %).
Conclusion: Our study found diffuse large B cell lymphoma (DLBCL) as the most common type of Non-Hodgkin’s Lymphoma. Cervical lymph nodes were found to be the most common site of involvement. But the involvement of rare sites like the testis and palate was also found. Hence the probability of NHL in these rare sites should always be considered.

 

Jithu Jacob, Swapna C Senan, Ramani Bhai,
Volume 19, Issue 2 (3-2025)
Abstract

Aim: The global distribution of Klebsiella pneumoniae that produce carbapenemase has been gradually increasing.This present study aimed to investigate the molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates from various clinical samples. Materials and Methods: In this study, 401 bacteria of Klebsiella isolates were isolated from various clinical samples according to standard protocol. The twelve carbapenem-resistant genes of Klebsiella pneumoniae isolates were detected using multiplex polymerase chain reaction (PCR). Results: Multiplex polymerase chain reaction (PCR) for identifying Class A β-lactamases producers (KPC), Class B β-lactamases producers (NDM), and Class D β-lactamases producers (OXA-48) were done. It was noted that 10 isolates expressed KPC followed by one isolate expressed NDM and one isolate expressed OXA-48. Conclusion: In the present study conclude that CP-CRK is a major health problem in the coming years and hence it is necessary to take all adequate measures to identify the resistant strains. Continuous monitoring of these resistant mechanisms is required to establish the changes in the prevalence and sensitivity pattern of MDR Klebsiella isolates. Urgent infection control measures coupled with antibiotic stewardship and strengthening of the healthcare infrastructure are to be instituted in our setting to prevent the spread of these Carbapenem-resistant genes of Klebsiella pneumoniae (KPC). Larger multicenter studies are required to thoroughly assess risk variables and historical trends in order to comprehend the dynamics of spread and efficient management strategies.



Page 1 from 1     

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.